POPULARITY
136 episodes with Abim
8 episodes with Abim
9 episodes with Abim
6 episodes with Abim
5 episodes with Abim
6 episodes with Abim
4 episodes with Abim
3 episodes with Abim
2 episodes with Abim
(00:00:00) Génerique et présentation (00:01:30) (1) Noémie MARIJON, Introduction (00:02:27) (2) Benjamin WEST, 1775 (00:04:20) (3) Rembrandt, 1665 (00:05:55) (4) Livre des Heures de Louis de Laval, 1470-1485 (00:06:35) Isaac et Abimélèk (00:07:08) La bénédiction de Jacob (00:07:46) (5) Conclusion - Gioachino Assereto, 1640 (00:08:34) Générique de fin Avec cet ultime épisode de notre série sur Rébecca, Noémie Marijon nous présente la figure de Rébecca dans l'art, parmi les enluminures, les œuvres de Rembrandt et de Benjamin West. Elle nous permet de découvrir et goûter à la richesse artistique de ces œuvres dont les références sont en description. NOTES · Benjamin WEST, Rébecca recevant le bracelet du serviteur d'Abraham, 1775 (Yale Center for British Art - New Heaven, Connecticut, USA) → wikimedia commons· REMBRANDT, La fiancée juive, 1665 (Rijksmuseum Amsterdam, NL) → wikimedia commons · Livre des Heures de louis de Laval, 1470-1485 (BnF) → Gallica / BnF : f.76r, 76v, 77r, 77v, 78r,· Bibliographie de N. Marijon : Irmtraud FISCHER, Des femmes aux prises avec Dieu, Récits bibliques sur les débuts d'Israël, Paris, Cerf, coll. Lire la Bible, 2008 | Michel PASTOUREAU, Rayures, une histoire culturelle, Paris, Seuil, 2021 | Jacqueline KELEN, Les femmes de la Bible, Paris, éd. du Relié, 2018 · BIBLIOGRAPHIE | CARTES & ILLUSTRATIONS · Plateformes d'écoute | Réseaux Sociaux | @Contact | Infolettre | RSS · Épisode enregistré en 05/2025 par Noémie Marijon & F. Bessonnet. Image de couverture : Benjamin WEST, Le serviteur d'Isaac attache le bracelet au bras de Rébecca, 1775 - source : Wikimédia Commons. Génériques : Erwan Marchand (D.R.). «Au Large Biblique» : podcast conçu et animé par François Bessonnet, bibliste.Sous Licence Creative Commons (cc BY-NC-ND 4.0 FR)Soutenez le podcast avec Tipeee ou Ko-fi CHAPITRES 00:00 Générique et présentation 01:30 (1) Noémie MARIJON, Introduction 02:27 (2) Benjamin West, 1775 04:20 (3) Rembrandt, 1665 05:56 (4) Jean Colombe, 1470-1485 07:46 (5) Conclusion 08:35 Générique de fin
durée : 00:16:55 - Les Midis de Culture - par : Marie Sorbier - Les critiques discutent de "Je le jure", le nouveau film de Samuel Theis, qui questionne les responsabilités du jury populaire de Metz. - réalisation : Laurence Malonda - invités : Raphaëlle Pireyre Critique de cinéma, elle publie régulièrement des articles sur le site AOC; Philippe Azoury Journaliste, critique et auteur
La prospérité d'Isaac suscite la jalousie violente des Philistins. Ceux-ci ne cessent de contester ses puits. Le patriarche doit alors quitter le territoire. NOTES · Abraham, le nomade de Dieu (10) Abraham et Abimélèk· BIBLIOGRAPHIE | CARTES & ILLUSTRATIONS· Plateformes d'écoute | Réseaux Sociaux | @Contact | Infolettre | RSS · Épisode enregistré en Vendée (85, France), 02/2025. Image de couverture : Rébecca et Éliézer, Alexandre CABANEL, 1883 - source : Wikimédia Commons. Génériques : Erwan Marchand (D.R.). «Au Large Biblique» : podcast conçu et animé par François Bessonnet, bibliste. Sous Licence Creative Commons (cc BY-NC-ND 4.0 FR)Soutenez le podcast avec Tipeee ou Ko-fi CHAPITRES 00:00 Générique et présentation 02:00 (1) De Guérar à Béer-Shéva 26,14-22 08:30 (2) D'Isaac à Jacob 11:20 (3) La promesse divine à Béer-Shéva 26,23-25 16:00 (4) L'alliance avec Abimélèk 26,26-33 24:30 (5) Conclusion : les épouses d'Ésaü 26, 34-3527:00 Générique de fin
Aujourd'hui dans "Punchline", Laurence Ferrari et ses invités débattent d'une liberté d'expression abimée suite à l'annonce de la fermeture de C8.
À Guérar, Isaac fait passer Rébecca pour sa sœur. Un épisode quasi-similaire à celui d'Abraham et Sara auprès de Pharaon (Gn 12) et d'Abimélèk (Gn 20). Quel est le sens de ces doublons ?NOTES · Abraham, le nomade de Dieu : (3) Abram et Saraï en Égypte | (10) Sara et Abimélèk· BIBLIOGRAPHIE | CARTES & ILLUSTRATIONS· Plateformes d'écoute | Réseaux Sociaux | @Contact | Infolettre | RSS · Épisode enregistré en Vendée (85, France), 02/2025. Image de couverture : La fiancée juive, REMBRANDT, 1665-1669 - source : Wikimédia Commons. Génériques : Erwan Marchand (D.R.). «Au Large Biblique» : podcast conçu et animé par François Bessonnet, bibliste. Sous Licence Creative Commons (cc BY-NC-ND 4.0 FR)Soutenez le podcast avec Tipeee ou Ko-fi CHAPITRES 00:00 Générique et présentation 01:40 (1) Une digression ?03:40 (2) Le renouvellement de la promesse 26,1-5 06:30 (3) Encore une épouse déguisée en sœur 10:00 (4) Le subterfuge découvert 26,6-11 16:45 (5) L'ascension d'Isaac 26,12-13 18:30 (6) Conclusion 22:16 Générique de fin
Paulo Brasil é cenógrafo, cenotécnico, artista gráfico, comunicador visual e ilustrador. Seu trabalho permeia pelo teatro, shows, arquitetura, vitrinismo e principalmente projetos cenográficos para diversas redes de TV do estado de Minas Gerias com cenários para telejornais, programas de debates, programa de entrevistas, dentre outros. Desenvolveu projetos cenográficos para feiras internacionais como BIO BRAZIL, em Miami/EUA; ABIMÓVEL - Brazilian Furniture, em Las Vegas/EUA; ABIMÓVEL- Exposição Abimóvel, em Valência na Espanha e em Tolure nos EUA. @paulobrasil58
In this podcast episode, Tom Serena, chief executive officer of the American Gastroenterological Association, discusses the role of private equity in specialty societies, the hunger to be involved in innovation and more. • Intro :24 • The interview/about Serena :29 • Can you tell us about your upbringing and how it helped you become who you are today? :50 • Were there certain early individuals or experiences that you think have been impactful or important to your career today? 1:43 • Have you always been a natural leader, or did you grow into it? 2:38 • What are some things you learned from your coach? 3:30 • Is there a pathway that you unintentionally took that led you to medical societies and medical society leadership? 5:09 • Over the thirty years you have been involved with the American Gastroenterological Association (AGA), when did you know that you were going to be a core part of the leadership team? 6:38 • How have you seen the GI field change over the last thirty years? 8:24 • Do you think there has been a shift in the culture of our specialty for major organizations like AGA to be more open to a wider range of physicians and stake holders? 11:00 • Where do you think we're going over the next few years with private equity? 14:08 • Can you tell us more about the AGA's GI Opportunity Fund? What prompted the AGA to partner with venture capital and how has the experience been so far? 19:19 • Are there things that organization leaders are more likely to invest or not invest in? 21:47 • Berry, Chey and Serena on non-traditional ways physicians are looking to make use of their medical training. 23:24 • How have larger legacy societies like AGA and ACG view the emergence of more nuanced clinical societies, and how do they impact the way the AGA tries to execute its mission? 27:05 • Can you talk about ABIM's impact on health care and the GI specialty? 30:01 • What are some of the biggest challenges facing AGA and GI as a field moving forward? 33:17 • Outside of the Opportunity Fund, what are other ways that the AGA is working to solve challenges around physician burnout, autonomy and reimbursement? 34:43 • Any life lessons you want to share with listeners? 36:22 • Thank you, Tom 37:39 • Thanks for listening 37:58 Tom Serena is chief executive officer of the American Gastroenterological Association. Tom joined AGA in 1994 and has served as the organization's CEO since 2010. His previous role was VP of finance. He has been heavily focused on governance, helping the governing board to become the stewards of AGA's future, with an emphasis on strengthening board - committee - staff relationships. We'd love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow us on X @HealioGastro @sameerkberry @umfoodoc. For more from Serena, follow @TSerenaAGA on X. For more from the AGA, visit www.gastro.org and follow @AmerGastroAssn on X. Disclosures: Berry and Chey report no relevant financial disclosures. Serena reports he is an investor in the GI Opportunity Fund.
Check out Dr. Mina's top picks for skin care here. Download the free eBook 'Skincare Myths Busted' here. Got a persistent dry patch, flaky scalp, or a rash that pops up with minimal sun? It might be more than just skin deep—it could be tied to an autoimmune condition! When dermatologists and rheumatologists work together, they can provide better care, treating both the skin and any other health issues tied to autoimmune conditions. This teamwork is especially helpful in managing conditions like lupus, psoriasis, or dermatomyositis, where the immune system affects the skin and other organs. Tune in to this week's podcast with @drbrittanypanico to learn about autoimmune conditions, their skin manifestations, how to choose between a dermatologist and rheumatologist, and the latest on treatment options. In this Episode: (4:40) Overlap Between Rheumatology and Dermatology (7:10) Understanding Autoimmune Conditions (16:07) All About Lupus (29:35) The Significance of a Positive ANA Test (33:39) Top 3 Tips for People with Autoimmune Conditions Key Takeaways: - Rheumatology and dermatology have significant overlap and collaboration is important for the management of autoimmune conditions. - Autoimmune conditions, such as lupus and psoriatic arthritis, can have both systemic and dermatologic manifestations. - A positive ANA test indicates immune system activation but does not provide a specific diagnosis. - Patients should advocate for themselves, seek further evaluation if symptoms persist, and maintain open communication with their healthcare providers. - Including all members of the healthcare team is crucial for comprehensive management of autoimmune conditions. ABIM board-certified in Internal Medicine and adult Rheumatology with experience in outpatient and inpatient care. Advocate of shared-decision making and informing patients and families about navigating the healthcare system. Experience navigating VA Healthcare. Chief of Rheumatology at Summit Rheumatology in Gilbert, AZ and OKC, OK. Gout Center of Excellence and Phoenix Magazine's Top Doc in 2022. Host of Eat Well Feel Well series about anti-inflammatory diet and recipes on Facebook and YouTube. Find Dr. Panico here: WEBSITE: Summitrheumatology.com YOUTUBE: https://www.youtube.com IG: https://www.instagram.com/drbrittanypanico/ FB: @drbrittanypanico Get Dr. Mina's free PDF on How to create Healthy Skin Habits here. Follow Dr. Mina here:- https://instagram.com/drminaskin https://www.facebook.com/drminaskin https://www.youtube.com/@drminaskin For more great skin care tips, subscribe to The Skin Real Podcast or visit www.theskinreal.com Baucom & Mina Derm Surgery, LLC Email - scheduling@atlantadermsurgery.com Contact - (404) 844-0496 Instagram - https://www.instagram.com/baucomminamd/ Thanks for listening! The content of this podcast is for entertainment, educational, and informational purposes and does not constitute formal medical advice.
Nurses Out Loud – We addressed follow-up emails on the controversial Ozempic episode, discussed emerging cancer research, homeschooling, organ donor hesitancy, the shameful decision by ABIM to strip several physicians of their Board Certifications due to Covid “Misinformation,” and more!
Nurses Out Loud – We addressed follow-up emails on the controversial Ozempic episode, discussed emerging cancer research, homeschooling, organ donor hesitancy, the shameful decision by ABIM to strip several physicians of their Board Certifications due to Covid “Misinformation,” and more!
Arnaud a assisté à l'explosion de son couple durant le covid. Depuis, il a mis sa vie affective de coté pour s'occuper de ses enfants. Abimé par sa précédente relation, il veut retrouver confiance en lui. Durant le mois d'aout, dans "Parlons-Nous", Stéphanie Van Oost accueille les auditeurs en direct pour 2h d'échanges et de confidences. Pour participer, contactez l'émission au 09 69 39 10 11 (prix d'un appel local).
Today's episode is a continuation on fast facts for the IM Board review focusing on the oncology questions. Another 6% of the certifying ABIM test is oncology. While we can't cover ALL of oncology in just 10 minutes, here are 10 high yield concepts/facts/vignettes you should know walking into your IM Boards.
Today's episode focuses on what you need to know to ace the hematology questions for your 2024 IM boards. 6% of the ABIM exam is hematology which includes erythrocyte, leukocyte and platelet disorders, coagulation disorders, transfusion medicine, and heme malignancies. We discuss some common vignettes & high yield points.
In this episode, Folarin is joined by his older brother Abim and they discuss Abim's summer job working for ABC and his time working for Dr Oz a few years back. They get into Abim's doctor origin story, the path to being a doctor, and what it's really like working in the emergency room. TIME STAMPS:Start – 4:30 Abim Intro4:30-8:00 NYC for the summer8:00-20:15 ABC news / Dr Oz 20:15-26:16 Disease of the day 26:16-35-35:32 Doctor origin story 35:32-38:40 Medical school experience38:40-47:26 Path to being a doctor 47:26-53:00 Working in the emergency room53:00-56:10 Tik Tok 56:10-59:20 Music identity Segment59:20-end Life in 10 years CREDITS:Hosted by Folarin OkulajaProduced by Folarin OkulajaEngineered by Folarin OkulajaSubscribe to Go With the Flo on Apple Podcasts, Spotify, or wherever you get your podcasts!https://www.youtube.com/channel/UCeheP4nl7aAFDmC8QgV-LUQhttps://open.spotify.com/show/0TCIEfodZuvVgnOVsho4lj?si=N3Pvw2hpR7u4979mwAZ5lQ&dl_branch=1https://podcasts.apple.com/us/podcast/go-with-the-flo/id1551569516
In this episode, Dr. Katie Fell (General Cardiology Fellow at University of Michigan and CardioNerds Academy Fellow) and Dr. Gurleen Kaur (incoming General Cardiology fellow at Brigham and Women's Hospital and Director of CardioNerds Internship) discuss with Dr. James Arrighi (General Cardiologist and CEO of ACGME-International) about developing as a clinician educator and the concept of competency-based education. The PA-ACC & CardioNerds Narratives in Cardiology is a multimedia educational series jointly developed by the Pennsylvania Chapter ACC, the ACC Fellows in Training Section, and the CardioNerds Platform with the goal to promote diversity, equity, and inclusion in cardiology. In this series, we host inspiring faculty and fellows from various ACC chapters to discuss their areas of expertise and their individual narratives. Join us for these captivating conversations as we celebrate our differences and share our joy for practicing cardiovascular medicine. We thank our project mentors Dr. Katie Berlacher and Dr. Nosheen Reza. The PA-ACC & CardioNerds Narratives in Cardiology PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Video version - Becoming a “Big E” Medical Educator as a Cardiologist with Dr. James Arrighi https://youtu.be/xcrwnz6_9Qg Quoatables - Becoming a “Big E” Medical Educator as a Cardiologist with Dr. James Arrighi “You really have to have a passion or a love for what you do...that's probably responsible for most of the success one has in life” (time 4:43) “Sub-subspecialty societies in Cardiology represent [a] great opportunity for junior faculty or even trainees to get involved, even before getting involved in ACC.” (time 5:30) “Competency-based medical education and time variable training are not synonymous.” (time 16:43) “As Cardiology evolves into more and more subspecialties...it begs the question... ‘Is Cardiology a primary specialty?'” (time 27:30) “We need to think about [a] more efficient ways for training.” (time 31:55) “As a clinician educator, there's variety, there's innovation!” (time 41:22) Notes - Becoming a “Big E” Medical Educator as a Cardiologist with Dr. James Arrighi How might one develop as a clinician educator on a national level? Junior faculty and trainees should consider taking advantage of education opportunities in various Cardiology sub-specialty societies (ex: American Society of Nuclear Cardiology, ASNC). This may include involvement in different committees. These opportunities are great ways to build connections and establish a reputation on a national level. This can help lead to other opportunities with larger national organizations (ex: ACC, AHA). Cardiology Training Oversight The Accreditation Council for Graduate Medical Education (ACGME) and American Board of Internal Medicine (ABIM) both have regulatory power over Cardiology training, providing the minimum clinical experience standards for Cardiology fellowship training programs.The ACGME oversees accreditation for Cardiology fellowships.The ABIM defines the requirements for eligibility for certification of individuals. Over time, the ACGME has transitioned to placing an emphasis on quality improvement, with a particular focus on continuous programmatic improvement. The American College of Cardiology (ACC) helps define more granular recommendations for Cardiology training programs and their curriculum.Periodically the ACC releases training guidelines for Cardiology fellowship programs, called Core Cardiovascular Training Statements, or COCATS. This document provides more contemporary, detailed, and specialty-specific recommendations for Cardiology training as compared to ACGME.While ACC has no regulatory authority over Cardiology training programs, COCATS documents provide a roadmap for program...
Dr. Aaron Goodman, who started a petition that gathered over 20,000 signatures to end the MOC back in July 2023, found himself suddenly reported as NOT CERTIFIED by the ABIM in the specialty he practices and teaches (hematology). When he called the ABIM, he was told he needed to pay thousands of dollars in back fees for the Internal Medicine Board that he did not want to keep, as he is a specialist in bone marrow transplant and hematology. The ABIM advised that unless he pays these fees, he will be deemed “not certified,” which threatens his ability to see patients at his own institution. Aaron was shocked and so was Chadi. The entire story is here. Learn what happened, what is next, and what can be done. Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on YouTube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA
✓ Kako su specijalistički ispiti postali dobar biznis? ✓ Zašto svi vole pare od pretplate? ✓ Ko zamrzava jajne ćelije?
Dr. Paul Teirstein, President of NBPAS.org, joins Chadi to highlight and reveal how the National Board of Physicians and Surgeons (NBPAS) is challenging the status quo of board certification for all medical practitioners. With a mission to advocate for physicians and combat the monopoly of Maintenance of Certification, Dr. Teirstein explains how NBPAS provides a refreshing alternative for continuous board certification. Visit the NBPAS website. https://nbpas.org/ View Dr. Teirstein debating Dr. Lois Margaret Nora of the American Board of Medical Specialties. https://www.youtube.com/watch?v=_fc3BQ-9yMM View Dr. Teirstein's MOC presentation. https://www.youtube.com/watch?v=h1vw2RPCd1s Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on YouTube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA
✓ Kako je Apple upao u nevolju? ✓ Kome je dovoljno 8 Gb RAM-a? ✓ Zašto su specijalistički ispiti slični Apple-ovim uslugama?
A conversation with Dr. Nicole Peoples, DO, ABIM, ABIHM, IFMCP, on a special crossover episode of Kult of Kindness --- Send in a voice message: https://podcasters.spotify.com/pod/show/kultofkindness/message
In the latest installment of the ABIM Maintenance of Certification (MOC) saga on Healthcare Unfiltered, the fiery aftermath of Aaron Goodman's groundbreaking petition to dismantle the ABIM MOC takes center stage. Joined by recurring guests, the outspoken Drs. Wes Fisher, Vincent Rajkumar, and Aaron Goodman himself, Chadi dives deep into the shifts within the medical landscape over the past six months. The conversation unfolds with a critical analysis of medical societies' responsiveness to the petition, exploring whether genuine change is underway or if inertia prevails. Together, they passionately discuss the crucial role of hospital and institution-wide rejection in catalyzing a domino effect for change. The episode doesn't shy away from the legal battlefield either, delving into the multiple class-action anti-trust cases against ABIM MOC. Tensions rise throughout the conversation, but it concludes with a collective focus on the next steps to propel this movement forward. Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on YouTube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA
According to the National Institutes of Health, more than two in five adults have obesity in the United States, and nearly one in three is overweight. To equip health care practitioners with the resources they need to treat patients with obesity, the Endocrine Society recently held its innaugual obesity fellows program, an exclusive, application-based, educational activity for current fellows. The program covered a wealth of information, and host Aaron Lohr talks with Amy Rothberg, MD, DABOM, program chair and a clinical professor of internal medicine at the University of Michigan’s School of Public Health. If you weren’t able to attend the fellows program, we have a free series of on-demand lectures available online, and those are accredited. With thanks to Lilly USA LLC and Novo Nordisk for making both the obesity fellows program and this podcast episode possible through an unrestricted, educational grant. Show notes, including a link to the Endocrine Society Learning Center for earning ABIM points and AMA PRA Category 1 credits, are available at https://www.endocrine.org/podcast/enp81-obesity-fellows-program — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast
According to the National Institutes of Health, more than two in five adults have obesity in the United States, and nearly one in three is overweight. To equip health care practitioners with the resources they need to treat patients with obesity, the Endocrine Society recently held its innaugual obesity fellows program, an exclusive, application-based, educational activity for current fellows. The program covered a wealth of information, and host Aaron Lohr talks with Amy Rothberg, MD, DABOM, program chair and a clinical professor of internal medicine at the University of Michigan’s School of Public Health. If you weren’t able to attend the fellows program, we have a free series of on-demand lectures available online, and those are accredited. With thanks to Lilly USA LLC and Novo Nordisk for making both the obesity fellows program and this podcast episode possible through an unrestricted, educational grant. Show notes, including a link to the Endocrine Society Learning Center for earning ABIM points and AMA PRA Category 1 credits, are available at https://www.endocrine.org/podcast/enp81-obesity-fellows-program — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast
According to the National Institutes of Health, more than two in five adults have obesity in the United States, and nearly one in three is overweight. To equip health care practitioners with the resources they need to treat patients with obesity, the Endocrine Society recently held its innaugual obesity fellows program, an exclusive, application-based, educational activity for current fellows. The program covered a wealth of information, and host Aaron Lohr talks with Amy Rothberg, MD, DABOM, program chair and a clinical professor of internal medicine at the University of Michigan’s School of Public Health. If you weren’t able to attend the fellows program, we have a free series of on-demand lectures available online, and those are accredited. With thanks to Lilly USA LLC and Novo Nordisk for making both the obesity fellows program and this podcast episode possible through an unrestricted, educational grant. Show notes, including a link to the Endocrine Society Learning Center for earning ABIM points and AMA PRA Category 1 credits, are available at https://www.endocrine.org/podcast/enp81-obesity-fellows-program — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast
Austin Perlmutter, MD, ABIM, joins Integrative Practitioner Content Specialist, Avery St. Onge, to discuss how climate change is contributing to brain disease and environmental and lifestyle interventions to improve brain immunity and reduce neuroinflammation. This episode is brought to you by the Integrative Healthcare Symposium. Register for the Symposium and receive 15% off with promo code IPpodcast: https://www.xpressreg.net/register/ihsy0224/landing.php?sc=IPpodcast Learn more about the event by visiting the Symposium website: www.ihsymposium.com Contact the Integrative Healthcare Symposium team: info@ihsymposium.com Find us at integrativepractitioner.com or e-mail us at IPEditor@divcom.com. Theme music: "Upbeat Party" by Scott Holmes via freemusicarchive.org, "Carefree" by Kevin Mcleod via incompetech.com, and “Relaxing Light Background” by AudioCoffee. About the Expert Austin Perlmutter, MD, ABIM, is a board-certified internal medicine physician, New York Times bestselling author, published researcher and international educator. His mission is to help people improve their health by targeting the biological basis of “stuckness” in our brains and bodies. His writing, presentations, podcasts, and online educational programs explore how environmental factors influence our cognitive and mental state and have reached millions. Dr. Perlmutter currently serves as the managing director at Big Bold Health, a food-as-medicine company focused on helping people rejuvenate health through better immune function, where he is running a first-of-its kind study exploring the effects of plant nutrients on human aging through epigenetics.
Dr. Clifford Hudis, the ASCO CEO, shares ASCO's approach to the continued ABIM-MOC saga. With many oncologists expressing their angst about the MOC process, ASCO, under his leadership, approached the situation methodically, sending a survey to its members to quantify the problem and explore next steps. This is the FIRST time the results of this survey are shared publicly. Learn about Dr. Hudis's inspiring career journey, his leadership style, and how he and ASCO are addressing this MOC Dilemma. This is a must-listen episode; be the first to know what has happened within ASCO and what the next steps might be. Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on Youtube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA
En 2016, Claude Pierre-Brossolette, ex secrétaire général de l'Elysée, a révélé que Valéry Giscard d'Estaing avait été impliqué dans un accident de voiture pendant son mandat. L'ancien président aurait raté un créneau avec la Ferrari de Roger Vadim. Tous les jours, retrouvez en podcast une archive des meilleures imitations de Laurent Gerra.
In this episode, Dr. Denise Sibley discusses the attempt by the American Board of Internal Medicine (ABIM) to strip the certification of high-profile medical freedom doctors, such as herself, because they are speaking against the official narrative. Tune in to learn what evidence she provided to the board in her recent hearing and what happens next. Reference Links https://www.denisesibleymd.com https://tnfreedomdoctors.org https://brownstone.org/articles/war-on-doctors-patients/
In this episode, Dr. Denise Sibley discusses the attempt by the American Board of Internal Medicine (ABIM) to strip the certification of high-profile medical freedom doctors, such as herself, because they are speaking against the official narrative. Tune in to learn what evidence she provided to the board in her recent hearing and what happens next.Reference Linkshttps://www.denisesibleymd.comhttps://tnfreedomdoctors.orghttps://brownstone.org/articles/war-on-doctors-patients/ Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Chadi is joined by Dr. Robert Brodsky, President of ASH, and Dr. Mikkael Sekeres, Chair of Communications at ASH, to discuss what led to the recent ASH statement on the ABIM MOC and to gather their reactions to the ABIM response and to what next steps might look like. The guests detail the relationship and progress made between ASH and ABIM since the beginning of the partnership in 2001, the process involved for ASH to eventually release a letter related to the MOC, the contents of the letter, the ABIM's response to the letter, and next steps needed to make progress toward a better system – including talking to hospitals and payers. If you have been following the ABIM-MOC issue, you cannot miss this podcast. Read ASH's letter. https://acrobat.adobe.com/link/review?uri=urn%3Aaaid%3Ascds%3AUS%3Ab1842c4c-22d9-3e59-be50-22e811ce5b70 Read ABIM's response. https://blog.abim.org/american-board-of-internal-medicine-response-to-american-society-of-hematology-statement/ Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on Youtube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA
Reader feedback, leadless pacing, ABIM, SGLT2 inhibitors, peri-operative MI after cardiac surgery, and. AHA late-breakers are the topics John Mandrola, MD, covers in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I. Reader Feedback Sep 22, 2023 This Week in Cardiology Podcast https://www.medscape.com/viewarticle/996694 - ODYSSEY OUTCOMES trial https://www.nejm.org/doi/full/10.1056/nejmoa1801174 - FOURIER https://www.nejm.org/doi/full/10.1056/nejmoa1615664 II. Leadless Pacing - Leadless vs Transvenous Pacemaker Study https://doi.org/10.1093/europace/euad269 III. ABIM News Heart Societies Ready to Split From ABIM Over Long-Standing MOC Disputes https://www.medscape.com/viewarticle/996747 IV. SGLT2 inhibitors Empagliflozin Gets FDA Nod for CKD Without T2D or HF https://www.medscape.com/viewarticle/996873 - EMPA-Kidney https://www.nejm.org/doi/full/10.1056/NEJMoa2204233 V. Peri-Op MI after Cardiac Surgery Cardiac Troponin Predicts Mortality Post Surgery https://www.medscape.com/viewarticle/996877 - Austrian Perioperative MI study https://doi.org/10.1016/j.jacc.2023.07.011 - Vision https://www.nejm.org/doi/10.1056/NEJMoa2000803 VI. AHA Late Breakers - Link to Late-Breakers https://professional.heart.org/en/meetings/scientific-sessions/programming/late-breaking-science#late-breaking You may also like: Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine https://www.medscape.com/features/public/machine The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net
This episode is sponsored by PearsonRavitz– a friend and advocate for physicians with their insurance needs. In this interview, Dr. Cassie Smith discusses her journey in medicine, particularly in the field of endocrinology. She initially wanted to be a doctor to help people but became frustrated with the limitations of pharmaceutical-based treatments. She eventually decided to focus on a holistic approach to healthcare, emphasizing healthy lifestyle choices and reducing dependency on medications. Dr. Smith also highlights the need for better education on nutrition and exercise, especially for children. She mentions several influencers and podcasters she follows for health and wellness advice and encourages patients to seek credible sources for information. Looking for something specific? Here you go! 00:03:30 Focus on holistic, non-pharmaceutical health. 00:05:03 Integrative approach to medicine. 00:13:39 Chronic disease requires lifestyle changes. 00:18:30 Healthcare system needs preventative measures. 00:20:43 Importance of health education. 00:27:06 Choose positive and informative content. 00:31:57 Chronic inflammation is multifactorial. 00:32:43 Inflammation stems from lifestyle choices. 00:38:48 Hormone replacement is important. 00:42:50 Hormones are crucial for health. 00:48:27 Testosterone can help with fibromyalgia. 00:53:44 Questioning pharmaceutical industry influence in medicine. 00:57:24 Doctors are hesitant to prescribe estrogen despite its potential benefits. 01:02:09 Inflammation and lifestyle affect thyroid. 01:09:13 Lifestyle changes are key. 01:14:57 Prioritize self-care for overall well-being. 01:16:17 Take care of yourself first. About Cassie Smith: Dr. Cassie Smith is a dual board-certified physician by the ABIM in Endocrinology, Diabetes, Metabolism and Internal Medicine who is an active member of seven different physician societies and associations in her specialty. She did her undergraduate and medical school at the University of Missouri Kansas City, which is one of three colleges in the country with a combined undergraduate and medical degree program completed in six years. She then transitioned to working on a dozen major clinical trials centered around diabetes care in fellowship at the Harold Hamm Diabetes Center in Oklahoma City. After fellowship, her insights in research and forward thinking made her a nationally sought-after public speaker for numerous international pharmaceutical companies for which she has presented hundreds of talks locally and nationally, on topics such as diabetes and thyroid disease. Dr Smith went into private practice in March 2020 after practicing for a large health system for several years following fellowship. Despite starting her practice just prior to COVID 19, she is the fasting growing private practice endocrinologist in Oklahoma City. Her knowledge, experience, and compassion won her a place on the Top Doctor List of 2022 in the 405 Magazine, and has placed her as a sought-after local specialist. She has also become a thought leader and expert in the field of bioidentical hormone replacement therapy. In 2022, Dr. Smith also began serving on the Medical Advisory Board for BioTe, a national industry-leading company with emphases on bioidentical hormone replacement therapy. In this role she educates physicians and practitioners nationally on how to diagnosis, administer, and treat patients with hormone and vitamin deficiencies. In November 2022, Dr. Smith decided to expand her practice and Modern Endocrine was born. She plans to continue using a holistic approach to treating patients with industry leading hormone therapy, comprehensive laboratory testing, preventative care, lifestyle modifications, and restorative medicine practices to personalize patient care and treatment plans for autoimmune and chronic diseases. As an expert endocrinologist, her goal is to help patients struggling with overwhelm make lifestyle changes to rebalance hormones and align their health. Find Dr. Smith here: https://www.modern-endocrine.com IG: modernendocrine_ FB: @Modern Endocrine You Tube: Modern Endocrine Tik Tok: @Modern Endocrine Our Advice! Everything in this podcast is for educational purposes only. It does not constitute the practice of medicine and we are not providing medical advice. No Physician-patient relationship is formed and anything discussed in this podcast does not represent the views of our employers. The Fine Print! All opinions expressed by the hosts or guests in this episode are solely their opinion and are not to be used as specific medical advice. The hosts, May and Tim Hindmarsh MD, BS Free MD LLC, or any affiliates thereof are not under any obligation to update or correct any information provided in this episode. The guest's statements and opinions are subject to change without notice. Thanks for joining us! You are the reason we are here. If you have questions, reach out to us at doc@bsfreemd.com or find Tim and I on Facebook and IG. Please check out our every growing website as well at bsfreemd.com (no www) GET SOCIAL WITH US! https://www.withkoji.com/@bsfreemd
Join Chadi in a thought-provoking discussion with Bryan Carmody, aka the “Sheriff of Sodium” and a pediatric nephrologist, as they tackle the challenges of the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Bryan shares his visionary solutions to simplify and improve the MOC process, shedding light on the potential benefits for physicians and patients alike. Whether you're a physician, healthcare professional, or just curious about the future of medical certification, this episode offers insights into a critical issue in modern medicine. View Dr. Carmody's YouTube discussions on the matter. https://www.youtube.com/watch?v=aNgf6oYZlcg https://www.youtube.com/watch?v=2SsU2Y40XwY View “The Sheriff of Sodium” blog. https://thesheriffofsodium.com/page/6/ Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on Youtube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA
So much has happened since the petition against the ABIM MOC started on 7/21/2023, which is nearing 20,000 signatures. Physicians have called upon their societies and organizations to offer statements on their behalf, but only The Society for Cardiovascular Angiography & Interventions (SCAI) so far has done so. Drs. Srihari Naidu and Allison Dupont, both members and leaders of SCAI, come on the show to explain why they came up with the statement and what it means to the membership. Is there a path forward and why have other societies stayed silent thus far? Drs. Naidu and Allison Dupont offer refreshing opinions as to what might get done and what is to come after the praise that SCAI received. Learn more about the SCAI. https://scai.org/ Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on Youtube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA
Dr. Wes Fisher joins the show to continue highlighting ABIM recertification and the MOC program following a petition that has gathered over 12,000 signatures to end this program. Dr. Fisher is a clinical cardiac electrophysiologist at NorthShore University HealthSystem in Evanston, IL; he is also a clinical Associate Professor at the University of Chicago Pritzker School of Medicine. Dr. Fisher is triple board-certified in Internal Medicine (Grandfathered per the ABIM), cardiology, and cardiac electrophysiology. He is due for his FOURTH re-certification in cardiology after 12/31/2023 and FOURTH re-certification in EP after 12/31/2023. The process of re-certification and MOC became a core center in Dr. Fisher's advocacy on behalf of the physicians. He co-founded Practicing Physicians of America to advocate and educate and has done significant investigative work on the ABIM; you can see much of his writing on his blog as well as many other outlets. Why does a respected EP physician, with over 3 decades of experience and thousands of patients seen, need to do this re-certification again and pay yearly dues? Please listen to this exclusive revealing podcast and share with your colleagues. This is another ABIM-related MUST LISTEN podcast. Read more about Practicing Physicians of America. https://practicingphysician.org/join/ View Dr. Fisher's blog. https://drwes.blogspot.com/ Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on Youtube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA
A lot has been stated about the Maintenance of Certification (MOC) implemented by the American Board of Internal Medicine (ABIM,) and many physicians, regardless of specialty, have been opposed to the MOC as it adds cost, burden, and takes away from patient care. This led Dr. Aaron Goodman from UCSD to start a petition to end the MOC, which gathered unwavering support with over 10,000 signatures in 2 weeks. In response, Dr. Richard Baron, the president and CEO of ABIM, has agreed to come on the show to address the concerns raised by physicians and to answer questions that have flooded all social media channels since the petition started. What is the history of certification, recertification, and MOC? What is the “Grandfather” rule? What about data? COI? Cost? Burnout? Does the MOC really lead to better patient care? Why not stick to state-regulated CME courses? These issues are top-of-mind for a large number of physicians who are certified by the ABIM. You will not want to miss this heated, yet respectful and civil, discussion. In the podcast, there is a mention of COIs. The ABIM has provided links to their COI. https://www.abim.org/about/boards-and-committees/board-policies/financial-conflict-of-interest/ and https://www.abim.org/about/boards-and-committees/board-policies/academic-conflict-of-interest/ Dr. Baron's specific COI are also listed. https://www.abim.org/about/leadership/#baron The ABIM Board of Directors page lists all of their COIs as well. https://www.abim.org/about/boards-and-committees/governance/board-of-directors/ Here is the page for all the Specialty Boards. https://www.abim.org/about/boards-and-committees/ View the petition. https://www.change.org/p/eliminate-abims-moc-requirement Check out Chadi's website for all Healthcare Unfiltered episodes and other content. www.chadinabhan.com/ Watch all Healthcare Unfiltered episodes on Youtube. www.youtube.com/channel/UCjiJPTpIJdIiukcq0UaMFsA
In this Allergy, Immunology, and Inflammation Assembly podcast, we share a recording of the webinar entitled “The New Longitudinal Knowledge Assessment (LKA): ABIM updates for Physicians Certified in Pulmonary Disease, Critical Care Medicine, and Sleep Medicine” that was moderated by Dr. Michelle Manni. During this webinar, Florence Mickens, JD, who serves as the Program Operations Manager for the American Board of Internal Medicine, discusses the LKA and ways to maintain certification for pulmonary disease, critical care medicine, sleep medicine and internal medicine as well as accommodations that have been made during the Covid pandemic. Drs. Laura Evans, Lynn Tanoue, and Jose Gomez-Villalobos join the conversation as discussants.
In the latest episode of the UnsCripted Medicine Podcast, listen in as we navigate the complexities of medical licensing, the erosion of expertise, and the pursuit of truth in medicine. Hosting this week is Andrew who is joined by two guests: Dr. Richard Baron (CEO, ABIM) and Professor Carl Coleman (JD, Seton Hall Law School) who published a thought-provoking paper titled Protecting the Legitimacy of Medical Expertise in the NEJM this last February. In this paper, they discuss the historical significance of licensing, the public's reliance on them, and recent laws passed that are challenging expertise and the institutions that validate it. Hear them further discuss the state of medicine and the threats to our profession.Original article: https://www.nejm.org/doi/full/10.1056/NEJMp2214120
Age is a main factor when determining cancer care. In this ASCO Education podcast we speak to one of the top leaders in treatment for older patients who has also credited mentorship as a foundation for his career. Dr. Hyman Muss describes his childhood in Brooklyn, serving as a general physician for troops in Vietnam (6:18), the doctor who influenced his choice of hematology and oncology (7:48) and creating one of the first geriatric oncology fellowships in in the country (21:58). Speaker Disclosures Dr. David Johnson: Consulting or Advisory Role – Merck, Pfizer, Aileron Therapeutics, Boston University Dr. Patrick Loehrer: Research Funding – Novartis, Lilly Foundation, Taiho Pharmaceutical Dr. Hyman Muss: None More Podcasts with Oncology Leaders Oncology, Etc. – Devising Medical Standards and Training Master Clinicians with Dr. John Glick Oncology, Etc. – Rediscovering the Joy in Medicine with Dr. Deborah Schrag (Part 1) Oncology, Etc. – In Conversation with Dr. Richard Pazdur (Part 1) If you liked this episode, please follow the show. To explore other educational content, including courses, visit education.asco.org. Contact us at education@asco.org. TRANSCRIPT Pat Loehrer: Welcome to Oncology, Etc., an ASCO Education Podcast. I'm Pat Loehrer, director of Global Oncology and Health Equity at Indiana University. Dave Johnson: And I'm Dave Johnson of Medical Oncology at the University of Texas Southwestern in Dallas, Texas. If you're a regular listener to our podcast, welcome back. If you're new to Oncology, Etc., the purpose of our podcast is to introduce listeners to interesting and inspirational people and topics in and outside the world of Oncology. We have an inspirational guest today. Pat? Pat Loehrer: If you ask anyone who's achieved any level of success and how they've achieved it, most likely they'll mention a number of people who've influenced them along the way. Quite often, these people reflect on their mentors, and after a certain time of accomplishment and reflection, they begin to mentor others. This is very much what our next guest has done. Dr. Hyman Muss has been a mentor to me and to Dave, and he's one of the most outstanding, wonderful people in the world, and we're so excited to have him today. Dr. Hyman Muss served in the US Army in Vietnam, where he was awarded the Bronze Star Medal. He's an experienced Clinician Scientist, the Mary Jones Hudson Distinguished Professor of Geriatric Oncology at the University of North Carolina School of Medicine, and the Director of Geriatric Oncology Program at the UNC Lineberger Comprehensive Cancer Center Program. His interest in education and research is focused on cancer and older patients, and he is internationally recognized in this area. He's been the co-chair of the Alliance Committee on Cancer and Older Adults and won the BJ Kennedy Award from ASCO in Geriatric Care. His particular interest in research expertise is in the care of breast cancer patients, with a focus on the management of women who are of older ages. He's had a major interest in breast cancer survivorship and long-term toxicity of treatment and also served as the co-chair of the Breast Committee for the Alliance Group. He serves as a mentor for medical students, medical residents, junior faculty, and more recently, his Geriatric Oncology fellows. He served on the Board of Directors of the ASCO Foundation and on the ABIM, the American Board of Internal Medicine, where both Dave and I were privileged to work with him and witness his leadership and his deep breadth of knowledge. Dr. Muss, thanks for joining us today. Dr. Hyman Muss: What a pleasure to be here. Thank you so much for inviting me. My mother would have loved the introduction. Pat Loehrer: Well, speaking of that, tell us a little bit. You grew up in Brooklyn, so tell us a little bit about your parents. Your father was a dentist, I think, and your uncle was a general practitioner. So give us a little bit of the early life of Hy Muss. Dr. Hyman Muss: So I grew up in Brooklyn, New York. I was born and bred there. I went to Brooklyn Technical High School. I almost went to Brooklyn College, but I came back and went to Downstate Medical Center, which was just terrific. My tuition was $600 a year, but that's another story. My parents lived in the same neighborhood. My dad was a dentist, so we knew all the people. My uncle was the GP. You came into their office, sat down, and they saw you anytime, day or night, almost 24/7, something we're probably not going back to, but they had a profound influence on me. My uncle, as a GP, used to take me on house calls in Brooklyn when they were done, and he had an old Buick with MD plates. And I would go into these families, and they loved him, and they would give me ice cream and things. Maybe that's what made me a doctor. But it was a terrific and indelible experience. I had terrific parents. In those days, doctors and medical people usually lived in the same neighborhoods as their patients, so they really knew their people well. It was a terrific upbringing. I got to love medicine and have never had a look back. Dave Johnson: So your inspiration for a career in medicine obviously started at home. Tell us more about your formal education. You mentioned your high school education. What about college? And shortly thereafter? Dr. Hyman Muss: Yeah, well, I went to Lafayette College. I was not the best high school student, but I had good college board scores or whatever they called them then. And I went to Lafayette and I thought I was going to be a chemist, a chemistry major. But I took enough premed courses and I spent a summer in a lab building cyclic ketones. And everybody was outside sitting on the lawn of the campus. And I was in there with all these distillation apparatus, and I said, “I don't think I can do this the rest of my life.” So I applied to medical school, and I got into several medical schools. But my father at that time was dying of metastatic bladder cancer. He had been a heavy smoker, and he was still working as a dentist. He worked until the day he unfortunately died. But I got into Downstate. We lived in Brooklyn, and my uncle, the GP, said, "Hy, you need to come home and help take care of your dad." I'm an only child, so I did. And I had a wonderful experience at Downstate. Several years ago, I was listening to NPR and heard that one of my professors had won the Nobel Prize. Dr. Furchgott in physiology, one would have never thought. And I had a wonderful education and subsequently got into what was then Peter Bent Brigham in Boston, did my internship and residency there, joined the army and medical school, so I wasn't drafted, it was a program then. And then after first year of residency, I went to Vietnam, worked with an artillery battalion, a mystical experience, but no regrets. And then subsequently came back and did hematology and oncology at Brigham and at what was then the Jimmy Fund and Sidney Farber Cancer Center. And Tom Frei had just come. And I did hematology with a guy named Bill Moloney in Boston at Harvard. I'll tell you, a wonderful man. He was like a surrogate father. My dad had died by then, and I just feel I've had every opportunity to have a wonderful education and terrific mentors along the way. Dave Johnson: So we want to ask you about both of those gentlemen, but I would like to just, if I may, drop back to your experience in Vietnam. What was that like? Dr. Hyman Muss: Well, I was 27 years old and I was put as the doctor for 500 men in artillery. My job was to take care of the general health of the troops. Fortunately, we didn't have many casualties. It wasn't a front war like my uncle, who was a GP actually in World War II, landed in Normandy about a week later and went all through World War II as a doctor. But Vietnam was an unusual war, there wasn't really a front. So my experience was I would go out to fire bases, which were units of about 100 men in the jungle, go out three days in a week in a helicopter, do sick call, check people. I dealt with really alcohol problems, unfortunately, a lot of drug problems. You had young people with really not a lot to do during the day, nothing much to do, and no real goal of being there. I did that for a while, and actually, the reason I got the Bronze Star was because I set up– It was nothing like standing in front of a machine gun. I'm not that kind of brave guy, but I set up a drug amnesty program so I got a lot of support from our regular field people to do this, so we didn't have to keep sending kids home with dishonorable discharges. And I learned a lot. I think we were reasonably successful. I learned a lot about artillery. I think overall it was a great experience in my life. Dave Johnson: Tell us how your interest in hematology and oncology originated. Where did that come from? Dr. Hyman Muss: When I was an intern at the Brigham, Dr. Moloney was a very famous Harvard professor. He had studied war casualties after Hiroshima, he was one of the people that found the Philadelphia chromosome in CML. He was a guy that rounded on every single one of his leukemia patients every day. So I was an intern. So in those days I would go and see all the hematology people rounding because all the acute leukemia patients and all the serious cancer patients were right on the floors, right on the wards. We had 17-bed wards, and then we had some private rooms. And he loved what he did. And before I left for Vietnam, we didn't have Ara C and daunomycin. So every leukemia patient I saw died. This is '68 to '70. Yet we tried all these different regimens. Occasionally you got someone who did well for six months, a year. But his bedside manner was absolutely wonderful to me. He knew all the patients. He'd ask them about where they lived in Boston. His humanism was terrific, and yet I loved the diseases he treated. The stakes were high. We didn't have good treatment, and I decided that that's probably what I want to do. So when I was in Vietnam, I applied and got back in the Hematology Fellowship and came back and did that. I saw Ara C and daunomycin. I gave the chemotherapy to them, and he'd say, "Go up and treat Harry Smith with Ara C and daunomycin." I had the syringes in my pocket, guys. Forget about hoods and mixing. And I'd go up and treat them and the marrow would be gone within four or five days. I did a bone marrow. They published their regimen in the New England Journal called COD, C-O-D because they also gave vincristine. So it was cytarabine, vincristine, and daunomycin, the COD regimen. It fit Boston. And I saw it was like the emergence of cisplatin after Larry Einhorn. You saw people that never survived going into remission and I saw some remissions in AML and it cemented it. About my second year of residency, we had a child. I was running out of money. I was being paid $6,000 a year and I had the GI Bill. I went into Dr. Moloney and he talked with Dr. Franny Moore, who was head of surgery at the Brigham, and they made me the Sidney Farber Research Fellow, doubled my salary and I had to go to the Jimmy Fund and see cancer patients. And it so happened that was when Tom Frei came to Dana-Farber. And so I started rounding with Dr. Frei and seeing those patients. And I think the first day I walked in, I knew I wanted to do more than just leukemia because I saw groups of patients with every disease. We treated everybody with CMFEP, it didn't matter what cancer they had. And I just loved it and said, "My God, there's so much we can learn. What a great career." And so that got me into the oncology portion. And then I was offered to stay at Harvard. They were going to make me an assistant professor, but they wanted me to do lab work. And I knew my personality, it just wasn't for me. I worked with a lovely guy named Frank Bunn, one of the world's great hem guys in his lab, and he's still a close friend in his 80s. And he told me one day, he said, "Hy, I don't think the lab is for you." And he actually helped me get my first job at Wake Forest University, which turned out to be wonderful. So that's how I ended up with my circuitous in HemOnc. And it's really from great mentors, it's from Bill Moloney, it's from Tom Frei, Dave Rosenthal, tons of wonderful people along the way that not only taught me a lot, but they seemed to love what they do, which is a gift in life to love what you do and love the people you're doing it with. They instilled that in me. Pat Loehrer: From there you went to Wake Forest and there's a couple of colleagues down there, I believe, that inspired you, Charlie Spurr and Bill Hazzard, who was the founding founder of geriatrics. Tell us about that experience and how'd that shape your life. Dr. Hyman Muss: I was looking for a clinical job and I looked at Rochester, and I got snowed in one night in Wake Forest, and I said, “Where's the contract?” And I signed it. And my mother, who was living in New York City, didn't know where North Carolina was. My mother was from a family, was born over a candy store in Greenwich Village, and said, “Where are you going?” And then I showed her where it was, and she says, “They're going to kill you down there.” And it turned out to be one of the best decisions of my life. My wife Loretta, who both of you know so well, we got out of our VW with our dog and our daughter when we moved here, and VW bug, by the way, not a van, and she cried. It turned out it was one of the best opportunities. Charlie Spurr was an iconic oncology leader. He actually did some of the early work on nitrogen mustard in Chicago during the war, the first chemotherapy drug. He was a terrific leader. He had patients programmed in on those IBM punch cards. He had little cards for the protocols, CMFEP, CMF, AC on little laminated index cards. I learned so much from him, and he was to me, great leaders and great mentors morph from things they do themselves to teaching other people, and whose brains have the ability of having the same dopamine shot when you see one of your fellows or young faculty present a wonderful study as you do. And your brain isn't saying, “I wish I was up there.” It's saying, “Isn't this so cool that this young man or woman or fellow or medical student is doing such a wonderful job?” And I had something to do with providing the soil for this seed to grow. That's the kind of guy he was. And so it was wonderful there. And as I moved on, we got a new Chief of Medicine, Bill Hazzard. And I still hear from Bill on rare occasions, but Bill was one of the first geriatricians in the United States. He wrote the textbook, and his wish was that all the faculty and all the specialties get involved in a geriatric project. And so I had all those little index cards, and I looked and saw how many older people with metastatic breast cancer we'd given chemotherapy to. And these were little protocols, nothing like the protocols today, no 50-page consent forms, 50 pages of where your data is stored. They were like, here's the treatment, here's the dose mods. And I looked at those 70 patients with one of our residents, Kathy Christman, she may be retired now, but in any event, we wrote a paper and showed the old people did as well as the young with breast cancer. And we published it in JAMA. And it's one of the few papers in my career, I got no reviewers. They accepted the paper. I got no reviewers. So because I'm from Brooklyn, and my English is not what it should be, I had my friends read it to just make sure I didn't say anything egregious. But it got published and the next thing I know, my friends in medical oncology in the state were calling me. They said, “I got a 75-year-old woman here.” I'm saying, “Guys, I just wrote this paper. I really don't know anything about older people.” But slowly, with Bill Hazzard and others, I got more and more interested. I started reading about Geriatrics and I ended up making it a focal point of my career. It was kind of happenstance. And Bill was a wonderful mentor. And then as I subsequently moved on, I worked with terrific people like Harvey Cohen, Lodovico Balducci, and Martine Extermann, all of them heavily involved with ASCO over the years as well, and B.J. Kennedy. They were wonderful to work with. And BJ was inspirational because BJ would get up at an ASCO meeting and he'd say when he saw the age cut off, he'd say, “How come you didn't let old people on that study? There'd be 1000 people in the audience.” And so he really was a great mentor. And I had the bittersweet opportunity of writing his obit for JCO years ago and kept up with his family a few years, but he was a wonderful man. Dave Johnson: I'm just reflecting on the fact that today, patient registries are sort of mainstream, but certainly in the ‘70s, ‘80s, even into the ‘90s, having a list of patients with a particular disorder seemed almost novel in many respects. And to have that was a godsend. Dr. Hyman Muss: It was a godsend. I still remember those little file cards. And he called it the Oncology Research Center and it was a godsend. And you've got to remember, this is like ‘74, ‘75, it's a long time ago. Dave Johnson: So many of our listeners may not be as familiar with Wake Forest as they are with Duke and North Carolina, the other medical schools located there. But you were at right at a point where I mean, it was one of the top oncology programs in the country at that time. Still is, I don't mean to diminish it, but there was a who's who of people there at the time. And you were also involved in creating, I think, one of the first cooperative groups of sorts. It was the Piedmont Oncology Group. Tell us about that. Dr. Hyman Muss: Oh, yeah, well, that brings back memories. So the NCI at that time wanted to get more, I think, rural and other smaller places involved in research. And they put out an RFA to form like regional cooperative groups. And we formed the Piedmont Oncology Association, the POA. We actually did well for a few years. We wrote some really good studies. We got one or two New England Journal articles. I worked with all the people, mainly in the community, community docs who would go on, and put people on the protocol. I mean, I looked at all the X-rays and scans in a lot of these patients myself as part of the studies we did. And it turned out to be a wonderful organization and it's still run today by Bayard Powell, who is one of our terrific fellows who's the head of Oncology at Wake Forest. But after a while, we just couldn't compete with CALGB, of which I was a member of also, and ECOG and SWOG, even North Central Group, which was kind of formed in a similar venue, eventually merged. So we did a wonderful job for a while but the truth is we just didn't have the manpower to write studies for every disease site. So eventually we kind of petered out as a clinical trials group. But it's been maintained for educational programs and it's really served as a good resource for a lot of good education for the community oncologists who give most of the care in this country in the state. So it's been good. I think Pat kind of exceeded us with HOG, the Hoosier Oncology Group, which was in a similar vein. But it was a great experience and it was all Dr. Spurr, who thought of doing this and built it. Dave Johnson: Certainly, it was inspirational in many people in and outside of Wake Forest. So with such an idyllic life, what in the world possessed you to move north to Vermont? Dr. Hyman Muss: Well, you get this urgent life. You want to be a leader, you want to be a chief. Now, I tell younger people, if they love what they do, don't do it. So I got a wonderful opportunity at the University of Vermont to go up there and be Head of HemOnc. Chief of Medicine was a terrific guy, Burt Sobel. The university at that time, at one time it had a wonderful Oncology program. It had a federally funded cancer center with Irwin Krakoff and Jerry Yates, two other iconic guys. I don't know what the politics were but it had lost a tremendous amount of faculty, especially its clinical faculty, and they needed to rebuild it. And I went up and I thought, “Well, I'm in my 50s. This is going to be a great opportunity. If I don't do it now, I may never get the chance.” So I went up there and actually, it was a great opportunity. We hired terrific people. We got CALGB and we participated. We had actually a very good accrual for a small place and we had a very small but very effective cancer center. So it turned out to be a really good experience. I worked with wonderful people. I recruited some wonderful people. But over time, the issues of the business of medicine, all the issues that happened, I'm saying I'm kind of losing my focus on clinical care and clinical trials, which I love to do. I don't need to tell either of you. I mean, Dave, you've been chief and department chair and Pat has run cancer centers. After a while, the administrative tasks just were so overwhelming and I didn't enjoy them, that I said, “I've got to get back in some type of more clinical focus.” And that's when I decided to look around and fortunately found what's turned out to be a dream job at UNC. But it was a time of life. Maybe my ego got in the way of my logic. I don't regret it. I met and I think we rebuilt a wonderful clinical program. But you realize some of the resources of big places with- we never had the research infrastructure to hire a lot of people and get big programs going on and great translational programs, just didn't have the funding. But it was great, and I have no regrets. And I learned how to tolerate the cold weather. And I have a lovely daughter, Sarah, who still lives up there. So we get back occasionally. And I've kept up with a lot of the people there. There are some wonderful people at UVM. Pat Loehrer: From there, though, you were pulled down to North Carolina, where you've, again, built an incredible breast program there is outstanding. But you've created a Geriatric Oncology program, one of the first geriatric fellowships in oncology in the country. So tell us a little bit about that and what you feel may be your legacy is there at North Carolina. Dr. Hyman Muss: Well, I had the opportunity over the years when I was at Wake, really, I got to know Shelley Earp, who's our cancer center director. I think maybe you were close to him, Pat. The longest surviving cancer center director on the planet, or among them. And we were good friends. And North Carolina's legislature actually gave the University of North Carolina substantial funding to improve cancer care in North Carolina, not just research. And so I had talked with Shelley about maybe moving, and because of the generosity of the state, really, he was able to really get me going, start a Geriatric Oncology program. And what I wanted to do was develop trials. As Dave says, I built a registry in 2009 here for older cancer patients using geriatric assessment. I have 2000 patients, which has been a resource for all types of faculty and fellows, and students to write papers. But I was able, with the support, to do things like this right from the get-go. And plus, I joined probably one of the best breast groups on the planet with Lisa Carey and Chuck Perou, and Larry, terrific people, Claire Dees. I had great luck in doing this, so I was able to really focus, get great support from my colleagues to build studies focusing on older people. And then I had the great fortune of meeting Ned Sharpless, our prior NCI director. And Ned is one of the world's great aging biologists. And I don't mean aging as an adjective, he's really been a master on why we age, the biology of aging, cell senescence. So Ned taught me all about cell senescence and the mechanisms, especially the gene expression p16, which is like our own CDK inhibitor. And so I was able to start using his lab, collect samples, treat people with chemotherapy, follow them off with geriatric assessment. It was a great opportunity to do that here, and we got a lot of studies going and we showed what the pediatricians have known for years, that chemotherapy dramatically ages people, not just children, but adults. But it also allowed me to work with my colleagues in lymphoma and lung cancer to do little studies along the way. And we eventually then built a T32 program. We got a T32, which we're kind of completing now our first five years to train oncology specialists in geriatrics. So the way we do it is they can be surgical oncologists, GU, we had a GYN oncologist, medical. With their HemOnc training, they do a year where they work with the geriatricians, so they go on geriatric inpatient service for a month and they really learn about older people. And part of it is a project. So we've been able to build that and develop a lot of programs with that. And I should say we've been very successful with mentorship and with ASCO support for things like YIAs, the late and great Arti Hurria, who absolutely an amazing woman. Some of her legacy at ASCO, the YIAs, and things. We've been successful in applying for some. So we've been able to build a whole spectrum of med and hematologists. We have an interest in Myeloma and AML focusing on older people. We've been able to build a whole team approach, including translational projects related to older people. And it's just been a great opportunity, and hopefully, my legacy here will be, too, and I'm working on it. We have a wonderful guy, Bill Wood, who is very effective and has built this incredible coaching program to continue this legacy. Like many of us in this field, we are bothered because we all know the stats, we all know that first slide of the demographics of cancer, and yet it's been very hard in our culture to provide a lot of the services and build the clinical trials we need to best care for older people. It's still a major problem in this country. So as I cut back on my clinical care, I'm going to still advocate to try to improve the care of older people. Do geriatric assessment, build it into your clinical programs, get your hospitals to support you, convince them, build business plans, et cetera. And hopefully, that'll be my ultimate legacy, that we've made greater awareness of the older people, other than the usual stats, and we're really trying to care for them in a much more global sense, in a much more holistic sense than we've done. I hope we'll be successful. It's a slow haul, but we've got lots of great young people coming up through the pipelines, ASCO has been a great player in this. Many of you know people like Supriya Mohile and William Dale, Heidi Klepin, people, the next generation that's going to keep building this. So I hope the legacy will be that we get more buy-in, more interest, more trained people in other oncology-related subspecialties RadOnc, SurgOnc that will really focus on the care of older people. Dave Johnson: I don't think there's any doubt that that will be a part of your legacy Hy, but I think your legacy will be much broader than the world of geriatric oncology. Your mentorship leadership, your clinical skills, your educational capabilities, all of that will certainly last for many, many years in the future. Well, I don't want to bring up a touchy topic, but you yourself are geriatric and we're wondering what your plans are for your semi-retirement. I recognize you're not retiring, but what do you like to do outside of medicine? Dr. Hyman Muss: I'll tell everybody who's interested in hearing this. On Tuesday, I had my 80th birthday. Dave Johnson: Congratulations. Dr. Hyman Muss: And I think I'm one of the most blessed guys. I'm pretty healthy. I married up - my wife Loretta, who both of you, Pat Loehrer and Dave Johnson, know well. Dave Johnson: Yeah, you definitely married up. Dr. Hyman Muss: Yes. It's really carried me most of my life. She's great and so she flew up our three kids and we celebrated and I'm very fortunate. I have the enthusiasm and strength to do more clinical medicine. But I think the time has come for me to cut back my clinical medicine, so I'm going to do that in June. The hardest thing I've done is say goodbye to so many of my patients here. We've been blessed. We have a lovely family. We're pretty close. I'm never bored, probably you two know well, I love to do things like fishing, outdoor stuff. I've really gotten into woodworking, so I'm not going to be bored. But there will be a small piece out of me when I walk out of that clinic in June. I know that and my two close psychiatry friends think it's going to really be a hard fall, but I don't think so. I still have some grants. In fact, I'm working with a fellow in City of Hope, Mina Sedrak, who's been very involved in ASCO, too. We are hoping to get an R01 looking at senolytic drugs that may prevent aging, and exercise in older women with breast cancer to see if we can reverse the trends of chemo. So my brain is still on that stuff, but the clinical care is going to be tough. I had a note and for some reason, we talked about so many things. I wanted to mention that one of my great opportunities was joining the CALGB and then the Alliance and getting the support of Dr. Schilsky, Rich Schilsky, who's been one of the icons of ASCO to build cancer in the elderly working group with Dr. Harvey Cohen at Duke. And Harvey is one of the world's great geriatricians. And using that to get studies done, to incorporate studies with Arti Hurria on geriatric assessment, and really have it as a place where a lot of younger investigators could get started on a career in geriatric oncology. And that was really a great opportunity. It was kept on by Dr. Bertagnolli, who now is our NCI director, and I think was really the first group to really give good support for this. Dave Johnson: So we want to thank you very much for being our guest today. We also want to thank our listeners of Oncology, Etc. This is an ASCO Educational Podcast where we talk about oncology medicine and much more. So if any of our listeners have an idea or a guest they would like for us to interview, please email us at education@asco.org. To stay up to date with the latest episodes and explore other educational content, visit ASCO's website at education.asco.org. Thanks again for being our guest, Hy. Dr. Hyman Muss: My pleasure. Thank you so much. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.
To stay up to date with new treatments and standards of care medical oncologists in the United States are required to take the ABIM Maintenance of Certification exam, a ten-hour test, every ten years. This ASCO education podcast focuses on the Longitudinal Knowledge Assessment. An alternative test that offers more flexibility in medical certification. Our guests are Dr. Suresh Nair Physician-in-Chief of Lehigh Valley Cancer Institute in Allentown, Pennsylvania and Chair of the ABIM Medical Oncology Board and Dr. Olatoyosi Odenike, Associate Professor of Medicine at the University of Chicago and member of the ABIM Medical Oncology Board. Speaker Disclosures Dr. Suresh Nair: Research Funding - Bristol-Myers Squibb Recipient; Merck; Nektar Therapeutics; Mirati Therapeutics; Strata Oncology Dr. Olatoyosi Odenike: Consulting / Advisory Role – Abbvie; Impact Biomedicines; Celgene Recipient; Novartis; BMS; Taiho; CTI Biopharma; Threadwell therapeutics; Blueprint Medicines; SERVIER; Kymera; Bristol-Myers Squibb/Celgene Research Funding - Celgene; Incyte; Astex Pharmaceuticals; NS Pharma; Abbvie; Janssen Oncology; Oncothyrapy; Agios; AstraZeneca; CTI BioPharma Corp Recipient; Kartos; Aprea AB; Bristol-Myers Squibb; Daiichi Sankyo; Loxo; Novartis Resources To find out more about the ABIM LKA, go to https://www.abim.org/lka/ For a video walk-through, visit https://www.youtube.com/watch?v=C0-qaUQmQXc Sign in to the ABIM Physician Portal to sign up for LKA by June 30, 2023: https://portal.abim.org/ To find out more about how ASCO supports physicians engaged in ABIM MOC, go to https://old-prod.asco.org/meetings-education/continuing-education-moc If you are interested in joining the ABIM Item Writing Task Force for Medical Oncology, find out more and submit your application at: https://www.abim.org/about/boards-and-committees/openings/medonc-iwtf-physician/ If you liked this episode, please follow the show. To explore other educational content, including courses, visit education.asco.org. Contact us at education@asco.org. TRANSCRIPT Disclosures for this podcast are listed in the podcast page. Dr. Suresh Nair: The medical profession is one where new treatments and standards of care are being discovered and applied frequently, especially in oncology. Staying up to date with such practices allows the physician to provide the highest quality of care. How is this accomplished? By taking part in the Maintenance of Certification, or MOC. The traditional MOC assessment takes about 10 hours to complete and gives you ten years to be reported as certified before your next assessment is due. But given today's world where new treatments and standards of care are advancing rapidly, a more continuous assessment approach is warranted to help oncologists stay up to date. This ASCO Education Podcast explores a new alternative to the every decade MOC exam for medical oncology. It's known as the Longitudinal Knowledge Assessment or LKA. I'm Suresh Nair MD, the Physician Chief of the Lehigh Valley Topper Cancer Institute in Allentown, Pennsylvania, and Chair of the American Board of Internal Medicine Medical Oncology Board. I will guide you through a general overview of the LKA, what it is, how it works, what the advantages are, and top-level need-to-know information. Joining me is my medical oncologist colleague, Dr. Olatoyosi Odenike, who's a professor of medicine and director of the Leukemia Program at the University of Chicago and serves as a fellow member of the ABIM Medical Oncology Board. To begin, here are the essential differences between the ten-year maintenance of certification exam or MOC exam and the Longitudinal Knowledge Assessment, the LKA. Both are being used to help medical professionals maintain a working knowledge of the latest treatments and standards in use in their field. The MOC is administered every ten years at specified locations, lasts about 10 hours, and the results are available after two months. The LKA is another option. It has a five-year cycle during which you answer questions on an ongoing basis and receive regular feedback on how you're performing. Dr. Odenike has taken the LKA and the MOC. Toyosi, please describe the preparation and the actual experience of taking the traditional MOC test. How much time did you take to prepare for the exam and how did you fit that prep time into your busy schedule? Dr. Olatoyosi Odenike: Thank you so much, Dr. Nair. For the traditional MOC, I started preparing about six months ahead of time and it was challenging to find time to prep and to fit that into an already busy schedule. It came down to blocking out any available time, particularly on the weekends, in the few weeks leading up to the actual examination date. It was also challenging to find time to dedicate a whole day to taking the exam and traveling down to the test site to do so. Dr. Suresh Nair: Today, the LKA is another option for busy oncologists. In 2022, the American Board of Internal Medicine launched the LKA after years of working with and listening to the physician community to understand their needs. As long as you're meeting the LKA participation requirement and other MOC requirements you'll continue to be publicly reported as certified for your entire five-year LKA cycle. The LKA is designed to provide greater flexibility, more convenience, and more immediate feedback, helping physicians stay current. Dr. Odenike, what has been your experience so far with the LKA? Dr. Olatoyosi Odenike: So far, I have found the process far easier to navigate than the MOC. Registering for the LKA on the ABIM physician portal was very easy. There are 30 questions per quarter, and I chose to get weekly reminders of the due date, along with a link to access the portal and the LKA questions. I find this to be so convenient, I can determine when to access and complete the questions, which I have often done on block closer to the due date. You are able to do this and fit this in your schedule any way you choose, which is a big improvement on the traditional MOC. Dr. Suresh Nair: Is the LKA a big time commitment for you? 30 questions per quarter seems like a lot. How does it compare to the traditional ten-year model? Dr. Olatoyosi Odenike: There's a four-minute time limit per question. So technically, you can answer all 30 questions in one afternoon. Some physicians report doing this in two hours. Data gathered over the last year have shown that most participants answer questions in under two minutes. And how they approach it is unique to each person. Some set aside a little time each week to answer questions until they're finished. Others, like me, will do it all at once or over the course of one week near the end of the quarter. You could do one a day with your morning coffee if you wanted to. We have found the structure to be significantly more flexible than the traditional MOC. We have a question for you, Dr. Nair. Can physicians sign up for the LKA now, even if they're not due for an assessment? Dr. Suresh Nair: You can only sign up in the year that you're due, or rather, starting in the December prior to your due year. So, physicians due for an assessment in 2023 were able to enroll starting December 1, 2022. Physicians who are recently certified or who are not due for a few more years have to wait until their due year to sign up for the LKA. Dr. Olatoyosi Odenike: What is the last date to sign up for the LKA? Dr. Suresh Nair: The last day to enroll in 2023 is June 30. If you missed the enrollment date for the LKA this year, you can still opt to take the MOC exam in the fall without letting your certification lapse. MOC registration closes August 15. Dr. Olatoyosi Odenike: What happens if you don't pass after five years? Dr. Suresh Nair: If you don't pass after five years, you enter the grace period as long as you're meeting your other MOC requirements and will continue to be reported as certified during that time. You'll have one calendar year to pass the traditional MOC exam. In some ways, this is somewhat risk-free going with the LKA in that regard. Can physicians still take the MOC exam if they prefer to? Dr. Olatoyosi Odenike: The MOC exam is still available in spring and fall each year for most certificates, including med ONC and hematology, the LKA is just another option. Many physicians prefer to take the traditional exam or if they're certified in multiple specialties, they use both the exam and the LKA to balance their time and areas of expertise better. Some physicians take the LKA in hematology and/or medical oncology while using the exam to remain certified in internal medicine, for instance, or vice versa. I have a question for you, Dr. Nair. Who is eligible to take the LKA? How can physicians know if they're eligible? Dr. Suresh Nair: LKA is offered in 15 specialty areas. All board-certified physicians in their assessment due year, except those in a grace period, are eligible. All physicians certified before 1990, all physicians with a lapsed certification. In fact, I had trained in both hematology and oncology 30 years ago, and I practiced medical oncology at two academic community hospital systems. I actually signed up for the LKA this past year to regain certification in hematology that had lapsed after my first 10 years, and I've had a great experience. I have finished a year of taking the test. I've gotten assessments. I see what my strong points and weak points are. I've actually ordered the ASH_SAP and I'm reading up on my weak points and I'm continuing this process. It really starts growing on you. I'd like to thank Dr. Odenike for sharing your real-time experience in taking both the MOC and the LKA. I would like to extend an opportunity for all listeners interested in keeping their certifications through the LKA by going to the ABIM Physician portal www.abim.org. That's www.abim.org or go to the notes on the podcast page to access the link, as well as other resources. There you can keep track of assessment deadlines and progress, and it allows you to set reminders for assessments, points, and payments. I want to thank all of you for listening to this ASCO Education Podcast. The ASCO Education Podcast is where we explore topics ranging from implementing new cancer treatments and improving patient care to oncology well-being and professional development. If you have an idea for a topic or guest you'd like to see on the show, please email us at education@asco.org. To stay up to date with the latest episodes and explore other educational content, please visit education.asco.org. Thank you. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.
This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe
Richard J. Baron, MD, MACP, is president and CEO of the American Board of Internal Medicine and the ABIM Foundation. In this timely and important podcast, Baron discusses the history and mission of the ABIM and its role in healthcare in the United States. The ABIM, most recently, has taken on the issue of medical misinformation and how it has contributed to the deterioration of trust in medicine and science. Baron discusses, in detail, a recent piece in The New England Journal of Medicine where he and his co-author discuss the importance of the medical profession maintaining independence from political interference and the consequences of attempts to politicize medical issues. Baron expands on how this situation is having an impact on physicians, their patients, and medicine. As a bonus, host Mike Sacopulos and Dr. Baron discuss Baron's undergraduate degree in English and how those studies helped both his writing and his skills as a physician leader. Protecting the Legitimacy of Medical Expertise by Richard J. Baron, MD, and Carl H. Coleman, JD https://www.nejm.org/doi/full/10.1056/NEJMp2214120 https://www.abim.org/ Learn more about the American Association for Physician Leadership at www.physicianleaders.org
Richard J. Baron, MD, MACP, is president and CEO of the American Board of Internal Medicine and the ABIM Foundation. In this timely and important podcast, Baron discusses the history and mission of the ABIM and its role in healthcare in the United States. The ABIM, most recently, has taken on the issue of medical misinformation and how it has contributed to the deterioration of trust in medicine and science. Baron discusses, in detail, a recent piece in The New England Journal of Medicine where he and his co-author discuss the importance of the medical profession maintaining independence from political interference and the consequences of attempts to politicize medical issues. Baron expands on how this situation is having an impact on physicians, their patients, and medicine. As a bonus, host Mike Sacopulos and Dr. Baron discuss Baron's undergraduate degree in English and how those studies helped both his writing and his skills as a physician leader. Protecting the Legitimacy of Medical Expertise by Richard J. Baron, MD, and Carl H. Coleman, JD https://www.nejm.org/doi/full/10.1056/NEJMp2214120 https://www.abim.org/ Learn more about the American Association for Physician Leadership at www.physicianleaders.org
Abimélec asesina a sus setenta hermanos y se vuelve rey de Israel. Abimélec lucha contra Siquén, quienes se revelaron contra él. Se destruye Siguén y se captura Migdal Siguén. Abimélec es herido de muerte por una mujer y pide a su escudero que le de muerte antes para que no se diga que fue vencido por una mujer. Los jueces menores Tolá y Yaír viven y traen paz a Israel, pero con su muerte Israel se vuelve necio y se aparta de Yahvé. Yahvé pone a Jefté como juez de Israel, quienes estaban pereciendo a manos de los filisteos y los amonitas, ellos acuden a Jefté y éste, con el favor de Yahvé, vence a los enemigos de Israel. En Rut, Booze rescata todo lo de Elimélec, incluyendo a Rut, a quien toma por mujer y con quien concibe a Obed, de quien nacerá Jesé, quien concebirá a su vez a David... Hoy leemos Jueces 9-11; Rut 4; Salmo 137.A partir de enero del 2023, Fray Sergio Serrano, OP leerá toda la Biblia en 365 episodios. Además compartirá reflexiones y comentarios para ir conociendo más la Palabra de Dios al caminar por la Historia de la Salvación.Aquí puedes obtener más información y el plan de lectura.Un poco más de The Great Adventure Bible, la Biblia que seguirá el podcast de La Biblia en un Año:Codificación de colores para fácil referencia: Usa el famoso Sistema de Aprendizaje de la Cronología de la Biblia de The Great Adventure (“The Bible Timeline” ®️) creado por Jeff Cavins, experto en Sagradas Escrituras, y que es utilizado por cientos de miles de católicos para aprender a leer la Biblia.Artículos que te ayudan a comprender el panorama completo de la Historia de la Salvación.Recuadros con eventos clave que ayudan a identificar los puntos importantes en la Biblia.Cuadros detallados que ofrecen la visión panorámica de los personajes y eventos clave, las alianzas importantes, mapas y el contexto histórico.Mapas a todo color que ayudan a visualizar los lugares donde sucedieron las historias bíblicas.
Yahvé a Israel un nuevo juez: Gedeón. Gedeón lidera a Israel el oeste del Jordán. El ejército de Gedeón es reducido pero Gedeón se mantiene fiel a Yahvé y Dios le presagia la victoria. Gedeón lidera un ataque sorpresa que culmina en victoria para Israel. Gedeón persigue a los jefes de Madián para darle muerte. Gedeón vence con el favor de Yahvé y hay paz en Israel. Gedeón tiene a Abimélec. Gedeón muere e Israel vuelve a ser infiel a Dios. Rut obedece a su nuera y hace todo lo que ella le dijo, va a los pies de Booz mietras duerme y cuando Booz se da cuenta y la cuestiona, Rut responde con firmeza y lealtad, Booz reconoce la fe de Rut y le da su apoyo... Hoy leemos Jueces 6-8; Rut 3; Salmo 135.A partir de enero del 2023, Fray Sergio Serrano, OP leerá toda la Biblia en 365 episodios. Además compartirá reflexiones y comentarios para ir conociendo más la Palabra de Dios al caminar por la Historia de la Salvación.Aquí puedes obtener más información y el plan de lectura.Un poco más de The Great Adventure Bible, la Biblia que seguirá el podcast de La Biblia en un Año:Codificación de colores para fácil referencia: Usa el famoso Sistema de Aprendizaje de la Cronología de la Biblia de The Great Adventure (“The Bible Timeline” ®️) creado por Jeff Cavins, experto en Sagradas Escrituras, y que es utilizado por cientos de miles de católicos para aprender a leer la Biblia.Artículos que te ayudan a comprender el panorama completo de la Historia de la Salvación.Recuadros con eventos clave que ayudan a identificar los puntos importantes en la Biblia.Cuadros detallados que ofrecen la visión panorámica de los personajes y eventos clave, las alianzas importantes, mapas y el contexto histórico.Mapas a todo color que ayudan a visualizar los lugares donde sucedieron las historias bíblicas.
Dios bendice a Rebeca, quien era estéril, con mellizos: Esaú y Jacob. Esaú entonces, en medio de la necesidad, vende su primogenitura (la promesa de Dios en él) por un plato de comida. Isaac, niega a su mujer y la hace pasar por su hermana, Abimélec se da cuenta, lo reprende y procede a ayudarle y protegerle. Job habla de forma altanera y se condena pero Dios demuestra su amor y misericordia a través de su justicia divina... Hoy leemos Génesis 25-26; Job 15-16; Proverbios 2:20-22.A partir de enero del 2023, Fray Sergio Serrano, OP leerá toda la Biblia en 365 episodios. Además compartirá reflexiones y comentarios para ir conociendo más la Palabra de Dios al caminar por la Historia de la Salvación.Aquí puedes obtener más información y el plan de lectura.Un poco más de The Great Adventure Bible, la Biblia que seguirá el podcast de La Biblia en un Año:Codificación de colores para fácil referencia: Usa el famoso Sistema de Aprendizaje de la Cronología de la Biblia de The Great Adventure (“The Bible Timeline” ®️) creado por Jeff Cavins, experto en Sagradas Escrituras, y que es utilizado por cientos de miles de católicos para aprender a leer la Biblia.Artículos que te ayudan a comprender el panorama completo de la Historia de la Salvación.Recuadros con eventos clave que ayudan a identificar los puntos importantes en la Biblia.Cuadros detallados que ofrecen la visión panorámica de los personajes y eventos clave, las alianzas importantes, mapas y el contexto histórico.Mapas a todo color que ayudan a visualizar los lugares donde sucedieron las historias bíblicas.
Arguing over vaccines with your crazy relatives might raise your glucose more than desert; continuous glucose monitoring (CGM) for insight into diet, exercise, sleep, emotional stress, and more. Video: https://youtu.be/Cg55DR2s8uk Timecodes: 00:00 Intro to lifestyle medicine 02:30 ABIM recertification, left vs. right brain medicine, Attia's documentary 10:03 Continuous glucose monitoring (CGM) as a motivator, exploring root causes, the primary care doc crisis 19:25 Insulin resistance, matching carbs to your metabolism, vital role of protein intake & muscle mass, fasting, plant-based diets 31:53 Sleep quality, food choices, glycemic variability, glucose spikes & recovery periods, worry journaling 43:47 Public speaking, cortisol release & glucose levels 51:28 Social media & the news, memory recall, creating spaces to give the nervous system a break, biopsychosocial factors, the right brain approach 57:45 CGM data patterns, approaching exercise realistically, walking, “EPIC” workouts, positive vs. negative stress 1:07:54 The pandemic of emotional repression, teen metabolic health 1:18:20 Gender-specific considerations, alcohol 1:23:12 Environmental conditioning, the downside to working from home, the approaching societal tipping point, waking up 1:27:47 Second-selfing, audience capture, internal capitalism, final thoughts With Dr. Ronesh Sinha: https://www.culturalhealthsolutions.com/ Follow him on Instagram: https://www.instagram.com/roneshsinhamd/ Check out his Meta Health podcast: https://podcasts.apple.com/us/podcast/the-meta-health-podcast/id1581144869 All our prior episodes with Dr. Sinha: https://zdoggmd.com/tag/ronesh-sinha/ Video archive, audio podcast, music parodies, Supporter Tribe membership, merch, social media, and email: https://lnk.bio/zdoggmd Support us with a 1-time donation and get a personal email thank you from me: https://paypal.me/zdoggmd More about Dr. Z: https://zdoggmd.com/about-z
"This is a topic that needs more airing from the professional side" Dr. Yul Ejnes is an Internal Medicine doctor and Chair of the Board of Directors of the American Board of Internal Medicine. He joins Explore The Space Podcast to discuss the recent article in New England Journal of Medicine he co-authored about how the Board will deal with physicians who spread medical disinformation. The Explore The Space Merchandise Store is open! Please check it out Please subscribe to and rate Explore The Space on Apple Podcasts or wherever you download podcasts. Email feedback or ideas to mark@explorethespaceshow.com Check out the archive of Explore The Space Podcast as well as our Position Papers and much more! Follow on Twitter @ETSshow, Instagram @explorethespaceshow Sponsor: Elevate your expertise with Creighton University's Healthcare Executive Educational programming. Learn more about Creighton's Executive MBA and Executive Fellowship programs at www.creighton.edu/CHEE. Links: Article from ABIM published in New England Journal of Medicine on dealing with medical disinformation American Board of Internal Medicine website
Abimélec asesina a sus setenta hermanos y se vuelve rey de Israel. Abimélec lucha contra Siquén, quienes se revelaron contra él. Se destruye Siguén y se captura Migdal Siguén. Abimélec es herido de muerte por una mujer y pide a su escudero que le de muerte antes para que no se diga que fue vencido por una mujer. Los jueces menores Tolá y Yaír viven y traen paz a Israel, pero con su muerte Israel se vuelve necio y se aparta de Yahvé. Yahvé pone a Jefté como juez de Israel, quienes estaban pereciendo a manos de los filisteos y los amonitas, ellos acuden a Jefté y éste, con el favor de Yahvé, vence a los enemigos de Israel. En Rut, Booze rescata todo lo de Elimélec, incluyendo a Rut, a quien toma por mujer y con quien concibe a Obed, de quien nacerá Jesé, quien concebirá a su vez a David... Hoy leemos Jueces 9-11; Rut 4; Salmo 137. A partir de enero del 2022, Fray Sergio Serrano, OP leerá toda la Biblia en 365 episodios. Además compartirá reflexiones y comentarios para ir conociendo más la Palabra de Dios al caminar por la Historia de la Salvación. https://ascensionpress.com/LaBibliaEnUnA%C3%B1o (Aquí puedes obtener más información) y el plan de lectura. Un poco más de https://ascensionpress.com/products/the-great-adventure-catholic-bible-spanish-edition (The Great Adventure Bible), la Biblia que seguirá el podcast de La Biblia en un Año: Codificación de colores para fácil referencia: Usa el famoso Sistema de Aprendizaje de la Cronología de la Biblia de The Great Adventure (“The Bible Timeline” ®️) creado por Jeff Cavins, experto en Sagradas Escrituras, y que es utilizado por cientos de miles de católicos para aprender a leer la Biblia. Artículos que te ayudan a comprender el panorama completo de la Historia de la Salvación. Recuadros con eventos clave que ayudan a identificar los puntos importantes en la Biblia. Cuadros detallados que ofrecen la visión panorámica de los personajes y eventos clave, las alianzas importantes, mapas y el contexto histórico. Mapas a todo color que ayudan a visualizar los lugares donde sucedieron las historias bíblicas.
© 2020-2025 Ivy Podcast Discovery LLC
